Kalle Kisand

2.3k total citations
49 papers, 938 citations indexed

About

Kalle Kisand is a scholar working on Surgery, Rheumatology and Genetics. According to data from OpenAlex, Kalle Kisand has authored 49 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 18 papers in Rheumatology and 17 papers in Genetics. Recurrent topics in Kalle Kisand's work include Diabetes and associated disorders (16 papers), Osteoarthritis Treatment and Mechanisms (15 papers) and Pancreatic function and diabetes (12 papers). Kalle Kisand is often cited by papers focused on Diabetes and associated disorders (16 papers), Osteoarthritis Treatment and Mechanisms (15 papers) and Pancreatic function and diabetes (12 papers). Kalle Kisand collaborates with scholars based in Estonia, Finland and Sweden. Kalle Kisand's co-authors include Raivo Uibo, A. Tamm, Ann Tamm, Irina Kerna, Kristi Alnek, J. Kumm, Kaja Metsküla, Konstantinos Douroudis, Mare Lintrop and Kadri Haller and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kalle Kisand

48 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kalle Kisand Estonia 19 311 289 285 231 172 49 938
Alessandra Petrelli Italy 19 256 0.8× 280 1.0× 63 0.2× 376 1.6× 186 1.1× 39 901
I.R. Badell United States 21 309 1.0× 682 2.4× 101 0.4× 508 2.2× 529 3.1× 40 1.7k
Elizabeth Whalen United States 16 184 0.6× 246 0.9× 276 1.0× 725 3.1× 314 1.8× 27 1.4k
Joseph P. Michalski United States 19 176 0.6× 254 0.9× 304 1.1× 291 1.3× 114 0.7× 36 1.1k
Frank Waldron-Lynch United States 16 366 1.2× 253 0.9× 147 0.5× 356 1.5× 101 0.6× 35 859
Marc Feldmann United Kingdom 6 200 0.6× 152 0.5× 157 0.6× 428 1.9× 175 1.0× 8 858
Setsuya Naito Japan 18 151 0.5× 122 0.4× 274 1.0× 523 2.3× 115 0.7× 48 1.1k
Adrianos Nezos Greece 22 226 0.7× 281 1.0× 425 1.5× 462 2.0× 346 2.0× 62 1.5k
Yoshisuke Nose Japan 19 194 0.6× 155 0.5× 72 0.3× 530 2.3× 170 1.0× 71 1.1k
H M Moutsopoulos Greece 20 164 0.5× 318 1.1× 269 0.9× 244 1.1× 66 0.4× 41 1.2k

Countries citing papers authored by Kalle Kisand

Since Specialization
Citations

This map shows the geographic impact of Kalle Kisand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalle Kisand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalle Kisand more than expected).

Fields of papers citing papers by Kalle Kisand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalle Kisand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalle Kisand. The network helps show where Kalle Kisand may publish in the future.

Co-authorship network of co-authors of Kalle Kisand

This figure shows the co-authorship network connecting the top 25 collaborators of Kalle Kisand. A scholar is included among the top collaborators of Kalle Kisand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalle Kisand. Kalle Kisand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallaste, Anne, et al.. (2025). Long COVID and Biomarker Dysregulation—A Shift Toward Immune Exhaustion?. Medicina. 61(6). 996–996. 1 indexed citations
2.
Mathieu, Sylvain, Philip G. Conaghan, Niels Eijkelkamp, et al.. (2025). The relationship between circulating and tissue biomarkers and OA-related pain: A systematic literature review. Osteoarthritis and Cartilage Open. 7(4). 100684–100684.
5.
Rull, Kristiina, et al.. (2020). Single-Tube Multimarker Assay for Estimating the Risk to Develop Preeclampsia. The Journal of Applied Laboratory Medicine. 5(6). 1156–1171. 3 indexed citations
6.
Kisand, Kalle, Ann Tamm, Mare Lintrop, & A. Tamm. (2018). New insights into the natural course of knee osteoarthritis: early regulation of cytokines and growth factors, with emphasis on sex-dependent angiogenesis and tissue remodeling. A pilot study. Osteoarthritis and Cartilage. 26(8). 1045–1054. 43 indexed citations
8.
Kerna, Irina, Kalle Kisand, & Ann Tamm. (2013). Synonymous SNP influences Adam12 mRNA expression level in synovial tissue. Journal of Molecular and Genetic Medicine. 7(1). 321–2. 4 indexed citations
9.
Valdes, Ana M., Nigel Arden, A. Tamm, et al.. (2010). A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthritis and Cartilage. 18(5). 699–704. 25 indexed citations
10.
Kisand, Kalle, Irina Kerna, J. Kumm, Helgi Jónsson, & A. Tamm. (2010). Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples. Clinical Chemistry and Laboratory Medicine (CCLM). 49(2). 229–235. 44 indexed citations
11.
Douroudis, Konstantinos, et al.. (2010). Allelic variants in the PHTF1-PTPN22, C12orf30 and CD226 regions as candidate susceptibility factors for the type 1 diabetes in the Estonian population. BMC Medical Genetics. 11(1). 11–11. 22 indexed citations
12.
Kerna, Irina, et al.. (2009). Missense single nucleotide polymorphism of the ADAM12 gene is associated with radiographic knee osteoarthritis in middle-aged Estonian cohort. Osteoarthritis and Cartilage. 17(8). 1093–1098. 27 indexed citations
13.
Douroudis, Konstantinos, et al.. (2009). The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens. 74(5). 417–419. 14 indexed citations
14.
Douroudis, Konstantinos, et al.. (2009). Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults. Clinica Chimica Acta. 403(1-2). 226–228. 19 indexed citations
15.
Haller, Kadri, et al.. (2007). Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes. Diabetes/Metabolism Research and Reviews. 23(7). 567–571. 12 indexed citations
16.
Kisand, Kai, et al.. (2007). Propensity to excessive proinflammatory response in chronic Lyme borreliosis. Apmis. 115(2). 134–141. 10 indexed citations
17.
Kisand, Kai, Kai Kisand, Meeme Utt, et al.. (2004). Serological description of Estonian patients with Lyme disease, a comparison with control sera from endemic and non-endemic areas. PubMed. 293. 174–178. 1 indexed citations
18.
Kisand, Kai, et al.. (2001). The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. Journal of Gastroenterology. 36(4). 248–254. 50 indexed citations
19.
Kisand, Kai, Kalle Kisand, Anna–Liisa Karvonen, et al.. (1998). Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology. Apmis. 106(7-12). 884–892. 17 indexed citations
20.
Uibo, Raivo, et al.. (1995). Association ofHelicobacter pyloriand gastric autoimmunity: A population-based study. FEMS Immunology & Medical Microbiology. 11(1). 65–68. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026